Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

The anticonvulsant topiramate not only decreases ethanol consumption in alcohol dependence (AD) but also may produce several adverse events including cognitive impairment. Zonisamide is a structurally related anticonvulsant that is a promising agent for the treatment of AD and may have greater toler...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Psychopharmacol
Autors principals: Knapp, Clifford M., Ciraulo, Domenic A., Sarid-Segal, Ofra, Richardson, Mark A., Devine, Eric, Streeter, Chris C., Oscar-Berman, Marlene, Surprise, Caitlin, Colaneri, Laurie, Putnam, Meghan, Waters, Megan, Richambault, Courtney
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2015
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4276485/
https://ncbi.nlm.nih.gov/pubmed/25427171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000246
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars